A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways

Journal of Nutritional Biochemistry

Volumn 23, Issue 5, 2012, Pages 458-468

  Tsai, Kun Ling ^a,b   Huang, Yi Hsiang ^a,b   Kao, Chung Lan ^a,b   Yang, De Ming ^b   Lee, Hsin Chen ^a   Chou, Hsiang Yun ^a   Chen, Yu Chih ^a,b   Chiou, Guang Yuh ^b   Chen, Li Hsin ^a,b   Yang, Yi Ping ^a,b   Chiu, Tsan Hung ^c   Tsai, Chiou Sheng ^d   Ou, Hsiu Chung ^e   Chiou, Shih Hwa ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; CoQ10; Inflammation; NO; OxLDL; ROS

Indexed keywords

CASPASE 3; CYTOCHROME C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; UBIDECARENONE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; DNA DAMAGE; DOWN REGULATION; ENDOTHELIUM LESION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR MECHANICS; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

APOPTOSIS; DNA DAMAGE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; UBIQUINONE; UP-REGULATION; VITAMINS;

EID: 84859831151     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.01.011     Document Type: Article

References (40)

1. Lum H., Roebuck K.A. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001, 280(4):C719-C741.
2. Chen X.L., Zhang Q., Zhao R., Ding X., Tummala P.E., Medford R.M. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells. J Pharmacol Exp Ther 2003, 305(2):573-580.
3. 2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 2004, 286(3):H1001-H1007.
4. Cominacini L., Pasini A.F., Garbin U., Davoli A., Tosetti M.L., Campagnola M., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 2000, 275(17):12633-12638.
5. Dimmeler S., Zeiher A.M. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept 2000, 90(1-3):19-25.
6. Crane F.L. Biochemical functions of coenzyme Q10. J Am Coll Nutr 2001, 20(6):591-598.
7. Kalen A., Appelkvist E.L., Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989, 24(7):579-584.
8. Sarter B. Coenzyme Q10 and cardiovascular disease: a review. J Cardiovasc Nurs 2002, 16(4):9-20.
9. Potgieter M., Pretorius E., Oberholzer H.M. Qualitative electron microscopic analysis of cultured chick embryonic cardiac and skeletal muscle cells: the cellular effect of coenzyme q10 after exposure to triton x-100. Ultrastruct Pathol 2009, 33(3):93-101.
10. Schmelzer C., Lindner I., Rimbach G., Niklowitz P., Menke T., Doring F. Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 2008, 32(1-4):179-183.
11. Kon M., Kimura F., Akimoto T., Tanabe K., Murase Y., Ikemune S., et al. Effect of coenzyme Q(10) supplementation on exercise-induced muscular injury of rats. Exerc Immunol Rev 2007, 13:76-88.
12. Murad L.B., Guimaraes M.R., Vianna L.M. Effects of decylubiquinone (coenzyme Q10 analog) supplementation on SHRSP. Biofactors 2007, 30(1):13-18.
13. Wang H., Zhao X., Yin S. Effects of coenzyme Q10 or combined with micronutrients on antioxidant defense system in rats. Wei Sheng Yan Jiu 2008, 37(3):311-313.
14. Sohet F.M., Neyrinck A.M., Pachikian B.D., de Backer F.C., Bindels L.B., Niklowitz P., et al. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol 2009.
15. Hamilton S.J., Chew G.T., Watts G.F. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care 2009, 32(5):810-812.
16. Rosenfeldt F.L., Pepe S., Linnane A., Nagley P., Rowland M., Ou R., et al. Coenzyme Q10 protects the aging heart against stress: studies in rats, human tissues, and patients. Ann NY Acad Sci 2002, 959:355-359. [discussion 463-355].
17. Mabuchi H., Nohara A., Kobayashi J., Kawashiri M.A., Katsuda S., Inazu A., et al. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis 2007, 195(2):e182-e189.
18. Chapidze G., Kapanadze S., Dolidze N., Bachutashvili Z., Latsabidze N. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins. Georgian Med News 2005, (118):20-25.
19. Chapidze G.E., Kapanadze S.D., Dolidze N.K., Latsabidze N.E., Bakhutashvili Z.V. Combination treatment with coenzyme Q10 and simvastatin in patients with coronary atherosclerosis. Kardiologiia 2006, 46(8):11-13.
20. Ou H.C., Song T.Y., Yeh Y.C., Huang C.Y., Yang S.F., Chiu T.H., et al. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Appl Physiol 2010, 108(6):1745-1756.
21. Kuo W.W., Huang C.Y., Chung J.G., Yang S.F., Tsai K.L., Chiu T.H., et al. Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action. J Vasc Surg 2009, 50(4):849-860.
22. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986, 89(2):271-277.
23. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119(3):493-501.
24. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988, 141(7):2407-2412.
25. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260(6):3440-3450.
26. Bedner E., Li X., Gorczyca W., Melamed M.R., Darzynkiewicz Z. Analysis of apoptosis by laser scanning cytometry. Cytometry 1999, 35(3):181-195.
27. Lubrano V., Baldi S., Ferrannini E., L'Abbate A., Natali A. Role of thromboxane A2 receptor on the effects of oxidized LDL on microvascular endothelium nitric oxide, endothelin-1, and IL-6 production. Microcirculation 2008, 15(6):543-553.
28. Robbesyn F., Salvayre R., Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 2004, 38(6):541-551.
29. Marshall H.E., Merchant K., Stamler J.S. Nitrosation and oxidation in the regulation of gene expression. FASEB J 2000, 14(13):1889-1900.
30. Sanson M., Ingueneau C., Vindis C., Thiers J.C., Glock Y., Rousseau H., et al. Oxygen-regulated protein-150 prevents calcium homeostasis deregulation and apoptosis induced by oxidized LDL in vascular cells. Cell Death Differ 2008, 15(8):1255-1265.
31. Cheng J., Cui R., Chen C.H., Du J. Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic bax leading to apoptosis of differentiated endothelial progenitor cells. Endocrinology 2007, 148(5):2085-2094.
32. Rauscher F.M., Sanders R.A., Watkins J.B. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001, 15(1):41-46.
33. Zou M.H., Leist M., Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol 1999, 154(5):1359-1365.
34. Vindis C., Elbaz M., Escargueil-Blanc I., Auge N., Heniquez A., Thiers J.C., et al. Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. Arterioscler Thromb Vasc Biol 2005, 25(3):639-645.
35. Naito Y., Shimozawa M., Manabe H., Nakabe N., Katada K., Kokura S., et al. Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species. Eur J Pharmacol 2006, 546(1-3):11-18.
36. Takayama M., Yao K., Wada M. The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta. J Biomed Sci 2009, 16:57.
37. Dentelli P., Rosso A., Zeoli A., Gambino R., Pegoraro L., Pagano G., et al. Oxidative stress-mediated mesangial cell proliferation requires RAC-1/reactive oxygen species production and beta4 integrin expression. J Biol Chem 2007, 282(36):26101-26110.
38. Hoffmann J., Haendeler J., Aicher A., Rossig L., Vasa M., Zeiher A.M., et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001, 89(8):709-715.
39. Tsuneki H., Sekizaki N., Suzuki T., Kobayashi S., Wada T., Okamoto T., et al. Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. Eur J Pharmacol 2007, 566(1-3):1-10.
40. Shults C.W., Flint Beal M., Song D., Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp Neurol 2004, 188(2):491-494.